MedTrace Logo

Monitoring Asthma and COPD in Primary Care

NCT00542061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2010-03-09

No results posted yet for this study

Summary

The purpose of this study is to determine the clinical effectiveness and cost-effectiveness of a written expert advice for GPs on additional diagnostic, treatment, and referral of patients based on half-yearly monitoring routines for patients with COPD or ashtma with a persistent obstruction in primary care based on a multicentre randomised nested clinical trial

Conditions

  • Lung Diseases, Obstructive
  • Asthma

Interventions

DEVICE

half-yearly monitoring routine

A written expert advice for GPs on additional diagnostic, treatment, and referral of patients with asthma and COPD based on half-yearly monitoring routines (lung function assessments including extensive anamnese) supported by half-yearly visits of an AC nurse consultant to the general practices.

Sponsors & Collaborators

  • PICASSO: Partners in Care Solutions for COPD

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Tjard Schermer, PhD · Radboud University Nijmegen Medical Centre, department of general practice

  • Lisette van den Bemt, MSc · Radboud University Nijmegen Medical Centre, department of general practice

  • Chris van Weel, MD PhD professor · Radboud University Nijmegen Medical Centre, department of general practice

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2007-02-28
Completion
2008-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00542061 on ClinicalTrials.gov